Physician profile
Vincent B Lam
NPI 1477713576
$2,211.49
in general payments reported to CMS, 2019-2025
13 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.63 · 2020: $274 · 2021: $33.58 · 2022: $1,123 · 2023: $238 · 2024: $168 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,058.21 | 2022-2025 | |
| Alcon Vision LLC | $522.37 | 2019-2025 | Clareon, Tryptyr, Rocklatan |
| Sight Sciences, INC. | $245.98 | 2022-2023 | Sion Surgical Instrument, Omni Surgical System |
| Oyster Point Pharma, INC. | $142.52 | 2023-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $48.14 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $39.80 | 2024 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $23.61 | 2025 | Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $21.60 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $19.64 | 2025 | Xdemvy |
| Allergan, INC. | $19.44 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Aerie Pharmaceuticals, INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.